Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | deferoxamine | 5288674 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | deferoxamine | 5288674 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | deferoxamine | 5288674 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | deferoxamine | 5288674 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | deferoxamine | 5288674 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | calmidazolium | 4911 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | calmidazolium | 4911 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | calmidazolium | 4911 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | calmidazolium | 4911 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | calmidazolium | 4911 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | calmidazolium | 4911 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | calmidazolium | 4911 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | calmidazolium | 4911 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | calmidazolium | 4911 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | probucol | 10068193 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | probucol | 10068193 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | probucol | 10068193 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | probucol | 10068193 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | probucol | 10068193 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | probucol | 10068193 | drug-path |